High Mortality and Graft Loss after Infective Endocarditis in Kidney Transplant Recipients: A Case-Controlled Study from Two Centers

• Main Authors: Yanis Tamzali, Clément Danthu, Alexandra Aubry, Romain Brousse, Jean-François Faucher, Zhour El Ouafi, Pierre Rufat, Marie Essig, Benoit Barrou, Fatouma Toure, Jérôme Tourret
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Pathogens
• Subjects: infective endocarditis; kidney transplantation; survival analysis; graft failure; transplant infectious diseases
• Online Access: https://www.mdpi.com/2076-0817/10/8/1023

Kidney transplant recipients (KTRs) tend to develop infections with characteristic epidemiology, presentation, and outcome. While infective endocarditis (IE) is among such complications in KTRs, the literature is scarce. We describe the presentation, epidemiology, and factors associated with IE in KTRs. We performed a retrospective case/control study which included patients from two centers. First episodes of definite or possible IE (Duke criteria) in adult KTRs from January 2010 to December 2018 were included, as well as two controls per case, and followed until 31 December 2019. Clinical, biological, and microbiological data and the outcome were collected. Survival was studied using the Kaplan–Meier method. Finally, we searched for factors associated with the onset of IE in KTRs by the comparison of cases and controls. Seventeen cases and 34 controls were included. IE was diagnosed after a mean delay of 78 months after KT, mostly on native valves of the left heart only. Pathogens of digestive origin were most frequently involved (six <i>Enterococcus spp</i>, three <i>Streptococcus gallolyticus</i>, and one <i>Escherichia coli</i>), followed by <i>Staphylococci</i> (three cases of <i>S. aureus</i> and <i>S. epidermidis</i> each). Among the risk factors evaluated, age, vascular nephropathy, and elevated calcineurin inhibitor through levels were significantly associated with the occurrence of IE in our study. Patient and death-censored graft survival were greatly diminished five years after IE, compared to controls being 50.3% vs. 80.6% (<i>p</i> < 0.003) and 29.7% vs. 87.5% (<i>p</i> < 0.002), respectively. IE in KTRs is a disease that carries significant risks both for the survival of the patient and the transplant.